Evogene | EVGN - Sales Revenues

Stock Price
368.60
Daily Change
55.00 17.54%
Monthly
3.19%
Yearly
-31.00%
Q1 Forecast
309.23

Evogene reported $312K in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
CVR Partners USD 163.55M 5.01M Sep/2025
Evogene USD 312K 572K Sep/2025
Hawkins USD 244.1M 36.33M Dec/2025
Innospec USD 441.9M 2.2M Sep/2025
Koppers USD 485.3M 19.5M Sep/2025
Kronos Worldwide USD 456.9M 37.5M Sep/2025
Materion USD 444.8M 13.1M Sep/2025
Minerals Technologies USD 520M 12.4M Dec/2025
Rayonier Advanced Materials USD 352.84M 12.79M Sep/2025
Sensient Technologies USD 412.1M 2.1M Sep/2025
Stepan USD 590.28M 4.41M Sep/2025
Tronox USD 699M 32M Sep/2025
Valhi USD 503.5M 36.9M Sep/2025
WD-40 USD 154.42M 9.05M Sep/2025